LV10275B - Derivative of tricyclic pyridone - Google Patents
Derivative of tricyclic pyridone Download PDFInfo
- Publication number
- LV10275B LV10275B LVP-93-504A LV930504A LV10275B LV 10275 B LV10275 B LV 10275B LV 930504 A LV930504 A LV 930504A LV 10275 B LV10275 B LV 10275B
- Authority
- LV
- Latvia
- Prior art keywords
- compound
- formula
- agent
- oxo
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
- C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/15—Suppositories
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Electric Propulsion And Braking For Vehicles (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH22891 | 1991-01-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV10275A LV10275A (lv) | 1994-10-20 |
| LV10275B true LV10275B (en) | 1995-02-20 |
Family
ID=4182207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-93-504A LV10275B (en) | 1991-01-25 | 1993-06-08 | Derivative of tricyclic pyridone |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US5281711A (es) |
| EP (1) | EP0496274B1 (es) |
| JP (1) | JPH0739415B2 (es) |
| KR (1) | KR920014811A (es) |
| AT (1) | ATE140002T1 (es) |
| AU (1) | AU649302B2 (es) |
| BG (1) | BG61057B2 (es) |
| BR (1) | BR9200217A (es) |
| CA (1) | CA2058640A1 (es) |
| CZ (1) | CZ280258B6 (es) |
| DE (1) | DE59206676D1 (es) |
| DK (1) | DK0496274T3 (es) |
| ES (1) | ES2089252T3 (es) |
| FI (1) | FI920268A (es) |
| GR (1) | GR3021126T3 (es) |
| HU (2) | HU207072B (es) |
| IE (1) | IE920225A1 (es) |
| IL (1) | IL100702A (es) |
| IS (1) | IS3804A (es) |
| LT (1) | LT3473B (es) |
| LV (1) | LV10275B (es) |
| MX (1) | MX9200242A (es) |
| MY (1) | MY108199A (es) |
| NO (1) | NO920338L (es) |
| NZ (1) | NZ241341A (es) |
| RU (1) | RU2073678C1 (es) |
| SI (1) | SI9210067A (es) |
| UY (1) | UY23362A1 (es) |
| YU (1) | YU48221B (es) |
| ZA (1) | ZA92361B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0650966A1 (de) * | 1993-10-28 | 1995-05-03 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung eines Benzo(a)chinolizinon-Derivates |
| KR100295740B1 (ko) | 1998-09-17 | 2001-11-05 | 박영구 | N-치환된-하이드록시고리화알킬아민유도체의제조방법 |
| US7277767B2 (en) | 1999-12-10 | 2007-10-02 | Srs Labs, Inc. | System and method for enhanced streaming audio |
| US8445700B2 (en) | 2008-11-24 | 2013-05-21 | Council Of Scientific & Industrial Research | Process for the preparation of optically active N-benzyl-3 hydroxypyrrolidines |
| WO2014190140A1 (en) | 2013-05-23 | 2014-11-27 | Alan Kraemer | Headphone audio enhancement system |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU191427B (en) * | 1984-07-16 | 1987-02-27 | Budapesti Mueszaki Egyetem,Hu | Piezooptical effect reduced electrooptical light modulator |
| ZW17385A1 (en) * | 1984-11-06 | 1986-02-19 | Hoffmann La Roche | Tricyclic pyridine derivatives |
| US4889848A (en) * | 1984-11-06 | 1989-12-26 | Hoffmann-La Roche Inc. | Tricyclic pyridine derivatives |
| US4851418A (en) * | 1987-08-21 | 1989-07-25 | Warner-Lambert Company | Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent |
-
1991
- 1991-12-31 CA CA002058640A patent/CA2058640A1/en not_active Abandoned
-
1992
- 1992-01-06 US US07/818,653 patent/US5281711A/en not_active Expired - Fee Related
- 1992-01-15 HU HU9200128A patent/HU207072B/hu not_active IP Right Cessation
- 1992-01-16 AT AT92100637T patent/ATE140002T1/de not_active IP Right Cessation
- 1992-01-16 EP EP92100637A patent/EP0496274B1/de not_active Expired - Lifetime
- 1992-01-16 ES ES92100637T patent/ES2089252T3/es not_active Expired - Lifetime
- 1992-01-16 DE DE59206676T patent/DE59206676D1/de not_active Expired - Fee Related
- 1992-01-16 DK DK92100637.5T patent/DK0496274T3/da not_active Application Discontinuation
- 1992-01-17 ZA ZA92361A patent/ZA92361B/xx unknown
- 1992-01-20 AU AU10340/92A patent/AU649302B2/en not_active Ceased
- 1992-01-20 IL IL10070292A patent/IL100702A/en not_active IP Right Cessation
- 1992-01-20 MX MX9200242A patent/MX9200242A/es not_active IP Right Cessation
- 1992-01-21 NZ NZ241341A patent/NZ241341A/en unknown
- 1992-01-22 JP JP4029910A patent/JPH0739415B2/ja not_active Expired - Lifetime
- 1992-01-22 FI FI920268A patent/FI920268A/fi not_active Application Discontinuation
- 1992-01-22 CZ CS92182A patent/CZ280258B6/cs unknown
- 1992-01-23 BR BR929200217A patent/BR9200217A/pt not_active Application Discontinuation
- 1992-01-23 YU YU6792A patent/YU48221B/sh unknown
- 1992-01-23 KR KR1019920000892A patent/KR920014811A/ko not_active Application Discontinuation
- 1992-01-23 SI SI9210067A patent/SI9210067A/sl unknown
- 1992-01-23 MY MYPI92000106A patent/MY108199A/en unknown
- 1992-01-24 IS IS3804A patent/IS3804A/is unknown
- 1992-01-24 RU SU925010652A patent/RU2073678C1/ru active
- 1992-01-24 NO NO92920338A patent/NO920338L/no unknown
- 1992-01-24 IE IE022592A patent/IE920225A1/en not_active Application Discontinuation
- 1992-02-24 UY UY23362A patent/UY23362A1/es unknown
-
1993
- 1993-03-24 US US08/036,295 patent/US5326769A/en not_active Expired - Fee Related
- 1993-06-08 LV LVP-93-504A patent/LV10275B/lv unknown
- 1993-07-20 LT LTIP801A patent/LT3473B/lt not_active IP Right Cessation
-
1994
- 1994-02-14 BG BG98464A patent/BG61057B2/bg unknown
-
1995
- 1995-06-16 HU HU95P/P00231P patent/HU211259A9/hu unknown
-
1996
- 1996-09-23 GR GR960402492T patent/GR3021126T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW502012B (en) | N-acylaminoalkylhydrazinecarboximidamides | |
| EP3138834B1 (en) | Cyclohexene derivative, preparation method therefor, and pharmaceutical composition for preventing or treating metabolic diseases, containing same as active ingredient | |
| Yang et al. | Elevated resting [Ca2+] i in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR | |
| EP0058975B1 (de) | Substituierte N-(4-Indolyl-piperidino-alkyl)-benzimidazolone, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika | |
| Gangula et al. | Sepiapterin reverses the changes in gastric nNOS dimerization and function in diabetic gastroparesis | |
| Yoon et al. | Intermittent fasting: a promising approach for preventing vascular dementia | |
| KR20060065584A (ko) | Ｎ-페닐-피페라진 유도체 및 5ｈｔ2ｃ 수용체 관련 질환의예방 또는 치료 방법 | |
| CN103987386A (zh) | 具有有相称效果的调节活性的(rs)-2-(2-氧代-4-苯基吡咯烷-1-基)乙酰胺化合物、药物物质(变体)及其应用、其组合物(变体) | |
| LV10275B (en) | Derivative of tricyclic pyridone | |
| JP2006515618A (ja) | 置換アルキルアミドピペリジン類 | |
| CN110123700A (zh) | 一种舒缓眼周皱纹和改善肌肤黯淡的眼霜 | |
| CA2169247A1 (en) | Pharmaceutical compositions and method for the treatment of patients having fragile x syndrome and retarded maturities or affected by alzheimer's type diseases or huntington's chorea or who show similar symptoms of muscular hypotonie and similar s ates | |
| NO322359B1 (no) | 1-(syklisk amino)-alkylsykloheksanforbindelser, farmasoytiske preparater derav og deres anvendelse som antikonvulsive midler | |
| JP5301474B2 (ja) | ４−［２−（４−メチルフェニルスルファニル）フェニル］ピペリジン塩の液体製剤 | |
| EP0048132B1 (en) | The use of dihydro-1h-pyrrolizine-3,5(2h,6h)-dione as a cognition activator, pharmaceutical compositions containing that compound, and the production of such compositions | |
| NO127670B (es) | ||
| CA2369908C (en) | Protein/polypeptide-k obtained from momordica charantia and a process for the extraction thereof | |
| JPH0374359A (ja) | ４―（ｎ―置換アミノ）―２―ブチニル―１―尿素およびチオ尿素ならびにそれらの誘導体 | |
| US20230241150A1 (en) | Compositions and Uses Thereof | |
| NO762352L (es) | ||
| EP1753757B1 (de) | Substituierte 2,5-diaminomethyl-1h-pyrrole | |
| WO2005113497A1 (de) | Substituierte 5-aminomethyl-1h-pyrrol-2-carbonsäureamide | |
| DD251982A5 (de) | Verfahren zur herstellung von neuen in 11-stellung substituierten 5,11-dihydro-6h-pyride-(2,3-b)(1,4) benzodiazipin-6-onen | |
| IKEMOTO | D-neuron, ligand neuron of trace amine-associated receptor 1: Key of novel non-D2 receptor-binding antipsychotics | |
| 공성혜 | Effects of Metabolic Factors on Cognitive Function in Elderly Korean: A Prospective Community-Based Cohort Study |